Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03646136 · ClinicalTrials.gov registry record · NA

Post Hysterectomy Benefits of Retained Cystoscopy Fluid

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT03646136 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03646136, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

The purpose of this research study is to compare outcomes for women in two study arms that include retaining the cystoscopy distending fluid after minimally invasive hysterectomy verses completely emptying the cystoscopy distending fluid. The outcomes being measured for research purposes include the time spent to first spontaneous urination after surgery, rate of indwelling catheter insertion, length of recovery room stay, the amount of bladder discomfort immediately postoperative and over the first 24 hours postoperative, bladder symptoms over the first 24 hours postoperative, and patient satisfaction.

Interventions

  • PROCEDURE Retained fluid
  • PROCEDURE Emptied fluid

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2018-10-10
Est. Completion 2019-10-30
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03646136

The ClinicalTrials.gov registry entry for NCT03646136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Retained fluid is the first listed.

NCT03646136 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03646136 about?

NCT03646136 is a clinical study titled "Post Hysterectomy Benefits of Retained Cystoscopy Fluid". The purpose of this research study is to compare outcomes for women in two study arms that include retaining the cystoscopy distending fluid after minimally invasive hysterectomy verses completely emptying the cystoscopy distending fluid. The outcomes being measured for research purposes include the...

What is the current status of trial NCT03646136?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2018-10-10. Estimated completion is 2019-10-30.

What interventions are being tested in trial NCT03646136?

The interventions under investigation include: Retained fluid (PROCEDURE), Emptied fluid (PROCEDURE).

Who is sponsoring clinical trial NCT03646136?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.